Development of a Neutron Energy-Biased in-Air Figure-of-Merit for Predicting in-Phantom BNCT Neutron Beam Characteristics

  • D. L. Bleuel
  • R. J. Donahue
  • B. A. Ludewigt
  • J. Vujic

Abstract

Maximizing the efficacy of a Boron Neutron Capture Therapy (BNCT) modality requires improvements in two areas: development of better boron-delivering drugs and better tailoring of the epithermal neutron beam. Previous attempts at the latter have not always been successful in predicting optimal in-phantom results, often assuming that all neutrons within a certain “useful” energy range are equally valuable for BNCT purposes. Some studies have recognized that higher energy epithermal neutrons (~10keV) and more forward-directed neutrons provide more penetrating beams. This results in higher tumor doses at centerline phantom depths. The exact effect of neutron beam energy spectrum shaping for BNCT has not been thoroughly explored. One reason for this has been the usage of inappropriate and often misleading in-air figures-of-merit.

Keywords

Boron Oncol Assure Reso Boronophenylalanine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yanch, J.C., Zhou, X-l., and Brownell, G.L., “A Monte Carlo Investigation of the Dosimetric Properties of Monoenergetic Neutron Beams for Neutron Capture Therapy,” Radiation Research 126, 1–20 (1991).PubMedCrossRefGoogle Scholar
  2. 2.
    Coderre, J.A., Bergland, R., Capala, J., Chadha, M., Chanana, A.J., Elowitz, E., Joel, D.D., Liu, H.B., and Slatkin, D., “Boron Neutron Capture Therapy for Glioblastoma Multiforme using p-boronophenylalanine and Epithermal Neutrons-Trials Design and Early Clinical Results,” J. Neuro. Oncol. 33, 93–104 (1997).CrossRefGoogle Scholar
  3. 3.
    Bleuel, D.L., Donahue, R.J., Ludewigt, B.A., and Vujic, J., “Designing Accelerator-based Epithermal Neutron Beams for Boron Neutron Capture Therapy,” Medical Physics 25(9), 1725–1734 (1998).PubMedCrossRefGoogle Scholar
  4. 4.
    Chanana, A.D., “Boron Neutron-Capture Therapy of Glioblastoma Multiforme at the Brookhaven Medical Research Reactor, A Phase I/II Study, FDA IND 43,317, Protocol 4,” Med. Dep. Brookhaven Natl. Lab., Upton, NY 11973–5000, January, 1996.Google Scholar
  5. 5.
    Briesmeister, J.F., MCNP-A General Monte Carlo N-Particle Transport Code, Version 4B, Los Alamos National Lab, 1997.Google Scholar
  6. 6.
    Snyder, W.S., Fisher, Jr., H.L., Ford, M.R., and Warner, G.G., “Estimates for Absorbed Fractions for Monoenergetic Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom (Appendix B),” J. Nucl. Medicine, MIRD Supplement No. 3, Pamphlet 5 (1969).Google Scholar
  7. 7.
    Liu, H.B., Greenberg, D.D., and Capala, J., “An Improved Neutron Collimator for Brain Tumor Irradiations in Clinical Boron Neutron Capture Therapy,” Medical Physics 23(12), 2051–2061 (1996).PubMedCrossRefGoogle Scholar
  8. 8.
    “Photon, Electron, Proton and Neutron Interaction Data for Body Tissues,” ICRU Report 46, February 28 (1992).Google Scholar
  9. 9.
    Nigg, D.W., Wheeler, F.J., Wessol, D.E., Capala, J., and Chada, M., “Computational Dosimetry adn Treatment Planning for Boron Neutron Capture Therapy,” J. Neuro-Oncol., 33, 93–104 (1997).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • D. L. Bleuel
    • 1
    • 2
  • R. J. Donahue
    • 1
  • B. A. Ludewigt
    • 1
  • J. Vujic
    • 2
  1. 1.Ernest Orlando Lawrence Berkeley National LaboratoryBerkeleyUSA
  2. 2.Department of the Nuclear EngineeringUniversity of CaliforniaBerkeleyUSA

Personalised recommendations